Submitted by Anonymous (not verified) on 4 December 2025 - 9:15
Human medicines European public assessment report (EPAR): Tagrisso, osimertinib, Date of authorisation: 01/02/2016, Revision: 23, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Tagrisso, osimertinib, Date of authorisation: 01/02/2016, Revision: 23, Status: Authorised